tiprankstipranks
Ascend Wellness Holdings LLC (AAWH)
OTHER OTC:AAWH
US Market

Ascend Wellness Holdings LLC (AAWH) Earnings Dates, Call Summary & Reports

56 Followers

Earnings Data

Report Date
Aug 11, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.06
Last Year’s EPS
-0.12
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 13, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a generally constructive tone: significant regulatory progress and tangible brand, loyalty and margin improvements were highlighted, along with clear execution on retail expansion and CPG momentum. However, near-term pressures remain — sequential revenue and adjusted EBITDA declined, cash fell materially driven by interest payments and an arbitration settlement, and there was a temporary cultivation shutdown. Management expects modest top-line growth and stable adjusted EBITDA margins in Q2 and is positioning to benefit from rescheduling and densification over time.
Company Guidance
Management guided Q2 net revenue growth of 2–3% with adjusted EBITDA margin expected to hold in the low-20% range; full‑year CapEx remains ~ $20.0 million with most spend now directed to new store openings as the company plans to expand its footprint from 51 to at least 60 stores by year‑end (5 added YTD, 10‑store pipeline). As context, Q1 net revenue was $116.9M (‑3% seq) with retail $83.1M (‑2.2%) and wholesale $33.8M (‑5%); adjusted gross profit was $53.9M (46.1% margin, +70 bps) and adjusted EBITDA was $26.3M (22.5% margin, ‑12.9% seq). Quarterly cash was $60.9M (down $24.8M YTD) after $19.4M net operating outflows (including a $19.1M biannual interest payment and a $17M arbitration settlement), $4.8M investing outflows (including ~$5.2M CapEx and ~$3.6M M&A payments), and $0.6M financing outflows; no major debt maturities until July 2029. Management also noted they are evaluating the DOJ rescheduling impact on their Section 280E uncertain tax position and are positioning for potential uplist, wider banking access and credit‑card acceptance.
Regulatory Milestone — DOJ Rescheduling to Schedule III
U.S. DOJ issued an order rescheduling medical cannabis from Schedule I to Schedule III (Apr 23). Management views this as a constructive step that could unlock improved access to capital, credit card acceptance, banking engagement, and potential up-listing opportunities; DEA administrative hearing on adult-use rescheduling begins June 29.
Revenue and Adjusted EBITDA Ahead of Guidance
Q1 net revenue was $116.9 million (down 3% sequentially) and adjusted EBITDA was $26.3 million; management stated both revenue and adjusted EBITDA came in ahead of the company's guidance range and broader market expectations.
Improved Gross Profit Margin
Adjusted gross profit was $53.9 million (down 1.4% q/q) while adjusted gross profit margin expanded by 70 basis points to 46.1%, driven by increased verticality, optimized menu assortment and stronger margins on third-party product sales.
Retail Mix and Verticality Progress
Retail now represents 71.1% of net revenue (up 60 basis points sequentially) reflecting a continued shift to vertical sales that supports margin expansion and improved price per gram.
Loyalty and Payment Momentum
Loyalty membership grew over 34% sequentially; ~89% of transactions tied to Ascenders Club members who spent nearly 20% more per transaction. Ascend Pay adoption rose from 6.2% to 8% of transactions, a 29% increase quarter-over-quarter.
CPG and Brand Share Gains
Ascend reached the #2 brand house by sales and units across Illinois, Massachusetts and New Jersey combined; combined market share in these states grew 11% sequentially. Infused flower was up 37.5% sequentially. High Wired gained 44% more share and ranked #1 infused flower across the three states. Ozone relaunch drove a 2.6% vertical sales uplift.
Retail Expansion / Densification
Year-to-date the company added 5 new stores (3 Northeast, 2 Midwest) and has 10 additional stores in the pipeline; management expects to expand from 51 stores to at least 60 by year-end (subject to approvals) as part of a densification strategy to drive operating leverage.
Balance Sheet Cushion and Capital Plan
Ended Q1 with $60.9 million in cash and no major debt maturities until July 2029. 2026 CapEx expected to be ~ $20 million, with most spend directed to new store openings and tuck-in M&A optionality.
Localized Sales Strengths
Ohio transaction volumes increased 11.8% quarter-over-quarter driven by new store openings and a shift to consistent, transparent everyday pricing; more favorable seasonality and ramp of new stores expected to drive 2%-3% top-line growth in Q2.

Ascend Wellness Holdings LLC (AAWH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AAWH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 11, 2026
2026 (Q2)
-0.06 / -
-0.12
May 13, 2026
2026 (Q1)
-0.10 / -0.15
-0.09-66.67% (-0.06)
Mar 12, 2026
2025 (Q4)
-0.09 / -0.24
-0.08-200.00% (-0.16)
Nov 10, 2025
2025 (Q3)
-0.07 / -0.13
-0.130.00% (0.00)
Aug 07, 2025
2025 (Q2)
-0.07 / -0.12
-0.1-20.00% (-0.02)
May 12, 2025
2025 (Q1)
-0.07 / -0.09
-0.090.00% (0.00)
Mar 12, 2025
2024 (Q4)
-0.10 / -0.08
-0.0911.11% (<+0.01)
Nov 12, 2024
2024 (Q3)
-0.09 / -0.13
-0.05-160.00% (-0.08)
Aug 05, 2024
2024 (Q2)
-0.07 / -0.10
0.004-2600.00% (-0.10)
May 07, 2024
2024 (Q1)
-0.06 / -0.09
-0.110.00% (+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AAWH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 13, 2026
$0.57$0.57-0.18%
Mar 12, 2026
$0.50$0.49-1.00%
Nov 10, 2025
$0.64$0.70+9.61%
Aug 07, 2025
$0.47$0.52+11.61%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ascend Wellness Holdings LLC (AAWH) report earnings?
Ascend Wellness Holdings LLC (AAWH) is schdueled to report earning on Aug 11, 2026, After Close (Confirmed).
    What is Ascend Wellness Holdings LLC (AAWH) earnings time?
    Ascend Wellness Holdings LLC (AAWH) earnings time is at Aug 11, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AAWH EPS forecast?
          AAWH EPS forecast for the fiscal quarter 2026 (Q2) is -0.06.